CALIN (Celtic Advanced Life Science Innovation Network) a collaborative programme led by Swansea University’s Medical School is funded by the European Regional Development Fund through the Ireland Wales Cooperation programme. CALIN aims to engage and assist over 240 Small and Medium-sized Enterprises (SMEs) throughout Ireland and Wales by offering open access to a unique strategic international partnership involving 6 world leading higher educational institutions and global healthcare leaders Unilever and GE Healthcare. The 6 higher educational institutions are; University College Dublin, National University of Ireland Galway (NUI Galway), Tyndall National Institute, University College Cork in Ireland and Bangor University, Cardiff University and Swansea University in Wales.
A framework to respond to the regulatory needs of future nanomaterials and markets.
QCM for rapid label-free Bionano interface evaluation and screening of effectiveness of nano-targeting strategies for therapeutics.
Engineered nanomaterial mechanisms of interactions with living systems and the environment: a universal framework for safe nanotechnology.
Biological Foundation for the Safety Classification of Engineered Nanomaterials (ENM): Systems Biology Approaches to Understand Interactions of ENM with Living Organisms and the Environment.
Innovative, mechanistic-based strategies for delivery of therapeutic macromolecules across cellular and biological barriers.